Cargando…
A model for cancer-suppressive inflammation
In oncology, inflammation is generally regarded as a cancer-promoting process only. Here, we argue that this view may represent a misleading oversimplification. We present evidence from our own work and from the literature documenting cancer-suppressive aspects of inflammation. We propose that speci...
Autores principales: | Haabeth, Ole Audun Werner, Bogen, Bjarne, Corthay, Alexandre |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Landes Bioscience
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3494627/ https://www.ncbi.nlm.nih.gov/pubmed/23170261 http://dx.doi.org/10.4161/onci.21542 |
Ejemplares similares
-
Interleukin-1 is required for cancer eradication mediated by tumor-specific Th1 cells
por: Haabeth, Ole Audun Werner, et al.
Publicado: (2015) -
Molecular profiling of tumor-specific T(H)1 cells activated in vivo
por: Lorvik, Kristina Berg, et al.
Publicado: (2013) -
Inflammation driven by tumour-specific Th1 cells protects against B-cell cancer
por: Haabeth, Ole Audun Werner, et al.
Publicado: (2011) -
Tumor-specific CD4(+) T cells eradicate myeloma cells genetically deficient in MHC class II display
por: Tveita, Anders, et al.
Publicado: (2016) -
How Do CD4(+) T Cells Detect and Eliminate Tumor Cells That Either Lack or Express MHC Class II Molecules?
por: Haabeth, Ole Audun Werner, et al.
Publicado: (2014)